Nigrostriatal dopaminergic neurons (NSDA neurons)

Nigrostriatal dopaminergic neurons are a specialized population of nerve cells that originate in the substantia nigra pars compacta (SNc) and project their axons to the dorsal striatum, comprising the caudate and putamen (StatPearls, NBK539811). These neurons are fundamental to the regulation of voluntary movement and the functional integrity of the basal ganglia motor circuit (NIH, 2023). The progressive and selective degeneration of these neurons is the primary pathological hallmark of Parkinson's disease, resulting in the classic motor symptoms of tremors, rigidity, and bradykinesia (Parkinson's Foundation). While this entry describes a cell population rather than a single molecular target like a receptor or enzyme, it is the central focus of Parkinson's disease research and pharmacology (PubMed, PMID: 31203183). Drugs interacting with this system typically aim to compensate for the loss of endogenous dopamine by providing metabolic precursors or by mimicking dopamine's action at the synaptic level. Monitoring the density and health of these neurons is a key diagnostic tool, often performed using functional imaging of the dopamine transporter (DAT).

Other names

Nigrostriatal pathwayA9 dopaminergic neuronsSubstantia nigra pars compacta neuronsNigrostriatal dopaminergic system

Therapeutic strategies focus on restoring dopaminergic neurotransmission within this pathway through the administration of dopamine precursors (Levodopa), direct stimulation of postsynaptic dopamine receptors (agonists), or the inhibition of enzymes like MAO-B and COMT to prevent dopamine degradation (StatPearls, NBK539811).